IRCT2017013132326N1Completed未知
Assessment the efficacy of augmentation Flavonoid Quercetin to risperidon in treatment of autism spectrum disorders
Vice Chancellor for Research of Mashhad University of Medical Sciences0 sites70 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 3 years to 12 years (—)
- Sex
- All
Inclusion Criteria
- •The inclusion criteria: Of all patients with ASD, ranging in age from 3to 12years; Parent's Consent; No obvious organic disease; The lack of other psychiatric disorders; Not taking other psychoactive medications other than risperidone; IQ higher than 50 on the basis of Weiland test.
- •The exclusion criteria: In the absence of cooperation of parents after inclusion; the risk of any side effect or another disease that cause a problem in results.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Not Applicable
Intervention study on the effect of a flavanol-rich cocoa powder on postprandial blood pressure, glucose and fat metabolism in type 2 diabetics with stable metabolic controlE11Type 2 diabetes mellitusDRKS00012561Hochschule NiederrheinFachbereich Oecotrophologie12
Completed
Not Applicable
Clinical evaluation of add-on administration of flavoxate hydrochloride in nocturia patients resistant to an anticholinergic agentJPRN-UMIN000009999Department of Urology, University of the Ryukyus50
Completed
Not Applicable
Intervention study on regular intake of a flavanol-rich cocoa powder on blood pressure, glucose and fat metabolism in type-2 diabetics with stable metabolic controlE11Type 2 diabetes mellitusDRKS00011007Hochschule Niederrhein, Fachbereich Oecotrophologie42
Recruiting
Phase 4
Does giving higher dose of folic acid improve intolerance associated with methotrexate in patients of Rheumatoid arthritisCTRI/2023/04/051346PGIMER, Chandigarh
Recruiting
Phase 1
Evaluation of the prophilatic effects of the flavonoid Hesperidin Methyl Chalcone on Delayed Onset Muscle Soreness in humansMyalgiaM62.9RBR-7wvr64kniversidade Norte do Paraná